Spectrum Pharma IGF-1LR3 Pen: Boost Muscle Growth & Recovery
$220.00
Product Name: IGF-1 LR3 Pen (Spectrum Pharma)
Active Ingredient: Long Arginine 3-Insulin-like Growth Factor-1 (LR3 IGF-1), an 83-amino acid analog of human IGF-1
Presentation: Pre-filled pen format
Regulatory Status: For research and licensed medical use only
Key Applications: Muscle growth and recovery research
Description
Spectrum Pharma IGF-1 LR3 Pen: A Targeted Tool for Muscle Growth & Recovery Research
The Spectrum Pharma IGF-1 LR3 Pen delivers Long Arginine 3-IGF-1, a synthetic analog of human insulin-like growth factor-1 . LR3 IGF-1 is an 83-amino acid peptide that comprises the complete human IGF-1 sequence, with a key substitution of Arginine for Glutamic acid at position three, and a 13-amino acid N-terminal extension peptide .
This modified structure significantly enhances the peptide’s biological activity. The primary reason for its increased potency is its dramatically reduced affinity for IGF-binding proteins (IGFBPs) . This modification results in greater stability and a longer half-life compared to native IGF-1, making it a more potent research tool . The Spectrum Pharma IGF-1 LR3 Pen provides a precise and convenient delivery system for research protocols .
Mechanism of Action: A Targeted Anabolic Signal
IGF-1 LR3 works as a direct, downstream anabolic signal to muscle tissue . In the natural pathway, growth hormone (HGH) from the pituitary gland stimulates the liver to produce IGF-1, which then circulates to promote growth . IGF-1 LR3 bypasses this initial step, delivering the signal directly to the IGF-1 receptors in muscle cells . This direct action activates intracellular signaling pathways that drive cell proliferation and protein synthesis, supporting muscle growth and recovery .
Key Research Applications:
-
Muscle Growth and Recovery: IGF-1 LR3 is investigated for its capacity to promote lean tissue growth through the activation of satellite cells, which are crucial for muscle repair and hypertrophy . Research indicates that IGF-1 LR3 stimulates myoblast proliferation and enhances protein synthesis in skeletal muscle .
-
Tissue-Specific Research: Studies have demonstrated that IGF-1 variants like LR3 IGF-1 can promote growth in specific organs, such as the heart, kidney, and spleen . This highlights the compound’s potential as a targeted research tool.
Spectrum Pharma IGF-1 LR3 Pen: Quality and Administration
Spectrum Pharma provides this peptide in a convenient, pre-filled pen format, which is designed for accurate dosing and ease of use in research or clinical settings . The IGF-1 LR3 injection is prepared under strict sterile compounding standards to ensure purity and potency . This ensures that the product meets high-quality standards for research applications.
Clinical Research Dosing & Safety Considerations
Clinical and preclinical research provides important context for dosing and safety:
-
Reduced Binding Protein Interaction: The LR3 modification results in lower affinity for IGF binding proteins, which increases its bioavailability and potency . Preclinical studies have shown LR3IGF-I to be 2.5-3 times more potent than native IGF-1 in restoring growth in certain models .
-
Blood Glucose Regulation: One of the most significant metabolic effects of IGF-1 is its insulin-like action, which can lower blood glucose and increase the risk of hypoglycemia . This risk is amplified when IGF-1 is used in combination with insulin or growth hormone .
-
Potential Adverse Effects: Potential side effects associated with IGF-1 include allergic reactions, swelling, headaches, and in long-term overdose scenarios, acromegaly (excessive growth of bones in hands, feet, and face) . The potential for malignant tumor growth is also a significant concern .
Product Features
-
Pre-filled Pen Format: Enables precise and easy administration
-
Long R3 IGF-1: An 83-amino acid analog with enhanced biological potency
-
Pharmaceutical-Grade Quality: Prepared under strict sterile compounding standards
-
Research-Grade Application: Intended for licensed healthcare providers for research and clinical protocols
Top 10 Frequently Asked Questions
1. What is IGF-1 LR3?
IGF-1 LR3 is a synthetic analog of human insulin-like growth factor-1, modified to have enhanced potency, stability, and a longer half-life for research applications .
2. How does IGF-1 LR3 work?
IGF-1 LR3 directly activates IGF-1 receptors on muscle and other tissues, stimulating protein synthesis and cellular proliferation. It acts as a direct, targeted anabolic signal .
3. How does IGF-1 LR3 differ from HGH?
HGH (Human Growth Hormone) acts as a master upstream signal that triggers the liver to produce IGF-1. IGF-1 LR3 bypasses this step and works directly on the target tissues .
4. What are the primary research applications for IGF-1 LR3?
Muscle growth, recovery optimization, and tissue-specific growth studies. It is used in research for its anabolic and cell-proliferation properties .
5. What makes LR3 IGF-1 more potent than native IGF-1?
The key modification is an arginine substitution at position 3, which significantly reduces its binding to IGF-binding proteins, increasing its stability and bioavailability .
6. What are the potential risks of using IGF-1 LR3?
Potential risks include hypoglycemia (low blood sugar), injection site reactions, headaches, swelling, and a theoretical risk of promoting tumor growth. Long-term overuse can lead to acromegaly .
7. Is IGF-1 LR3 approved for medical use?
While IGF-1 is approved for specific medical conditions (like growth failure in children), IGF-1 LR3 is often provided as a compounded peptide for licensed healthcare providers and research, and is not FDA-approved as a standard medication .
8. What is the dosing schedule in research?
In animal research, daily injections (e.g., in rats, at doses of 2 or 5 µg per gram of body weight) have been used . Dosing is determined by research protocol and clinical judgment.
9. How should IGF-1 LR3 be stored?
Lyophilized IGF-1 LR3 should be stored at -20°C. After reconstitution, it should be stored at 2-8°C for up to two weeks or frozen for longer periods, with avoidance of freeze/thaw cycles .
10. Is IGF-1 LR3 a controlled substance?
Yes. IGF-1 and its analogs are considered prohibited substances by anti-doping agencies and are classified as doping substances in many countries .
Ready to take the next step?
Secure your supply of Spectrum Pharma IGF-1 LR3 Pen from a trusted source. Visit anabolicsteroidsonline.shop today to explore our selection of premium research products.







Reviews
There are no reviews yet.